142 related articles for article (PubMed ID: 7905252)
1. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E
Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252
[TBL] [Abstract][Full Text] [Related]
2. [Intracellular pH regulation in human SW-620 colon cancer cells].
Bischof G; Wenzl E; Weinlich M; Hamilton G; Feil W; Schiessel R
Wien Klin Wochenschr; 1990 Jun; 102(13):369-75. PubMed ID: 2382444
[TBL] [Abstract][Full Text] [Related]
3. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
Gollapudi S; Gupta S
Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
[TBL] [Abstract][Full Text] [Related]
4. p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.
Michieli M; Damiani D; Michelutti A; Melli C; Russo D; Fanin R; Baccarani M
Haematologica; 1994; 79(2):119-26. PubMed ID: 7914881
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
6. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
7. Intracellular expression of P-glycoprotein in a human colon tumor cell line.
Duensing TD; Slate DL
Anticancer Res; 1994; 14(1A):13-9. PubMed ID: 7513140
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
10. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.
Kang Y; Perry RR
Cancer Res; 1993 Jul; 53(13):3040-5. PubMed ID: 8100483
[TBL] [Abstract][Full Text] [Related]
12. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
Kavallaris M; Madafiglio J; Norris MD; Haber M
Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
[TBL] [Abstract][Full Text] [Related]
13. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
14. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
15. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
[TBL] [Abstract][Full Text] [Related]
16. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.
Keizer HG; Schuurhuis GJ; Broxterman HJ; Lankelma J; Schoonen WG; van Rijn J; Pinedo HM; Joenje H
Cancer Res; 1989 Jun; 49(11):2988-93. PubMed ID: 2566376
[TBL] [Abstract][Full Text] [Related]
17. Effects of amiloride treatment on U-118 MG and U-251 MG human glioma and HT-29 human colon carcinoma cells.
Szolgay-Daniel E; Carlsson J; Zierold K; Holtermann G; Dufau E; Acker H
Cancer Res; 1991 Feb; 51(3):1039-44. PubMed ID: 1846315
[TBL] [Abstract][Full Text] [Related]
18. Effects of P-glycoprotein expression on cyclic AMP and volume-activated ion fluxes and conductances in HT-29 colon adenocarcinoma cells.
Kunzelmann K; Slotki IN; Klein P; Koslowsky T; Ausiello DA; Greger R; Cabantchik ZI
J Cell Physiol; 1994 Dec; 161(3):393-406. PubMed ID: 7962123
[TBL] [Abstract][Full Text] [Related]
19. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression.
Hoffman MM; Roepe PD
Biochemistry; 1997 Sep; 36(37):11153-68. PubMed ID: 9287158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
